Skip to main navigation Skip to search Skip to main content

Evaluation of differential toxicity of varying doses of bevacizumab on retinal ganglion cells, retinal pigment epithelial cells, and vascular endothelial growth factor-enriched choroidal endothelial cells

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)507-511
Number of pages5
JournalJournal of Ocular Pharmacology and Therapeutics
Volume25
Issue number6
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

ASJC Scopus Subject Areas

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)

Keywords

  • Endothelial Cells/drug effects
  • Retinal Pigment Epithelium/drug effects
  • Species Specificity
  • Humans
  • Cells, Cultured
  • Rats
  • Antibodies, Monoclonal/administration & dosage
  • Bevacizumab
  • Haplorhini
  • Dose-Response Relationship, Drug
  • Antibodies, Monoclonal, Humanized
  • Animals
  • Flow Cytometry
  • Retinal Ganglion Cells/drug effects
  • Angiogenesis Inhibitors/administration & dosage
  • Cell Death/drug effects
  • Cell Proliferation/drug effects
  • Vascular Endothelial Growth Factor A/antagonists & inhibitors
  • Choroid/cytology
  • Microscopy, Fluorescence

Cite this